FTC challenges junk patents held by 10 drugmakers, including for Novo Nordisks Ozempic
The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.…
640,052SEK
-0,04%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
FTSE 100 continues record run boosted by Anglo American, AstraZeneca By Reuters
FTSE 100 continues record run boosted by Anglo American, AstraZeneca…
Truqap recommended for EU breast cancer approval
29 April 2024
Truqap plusFaslodex recommended for approval in the EU by CHMP for
patients with advanced ER-positive breast cancer
Recommendation based on CAPItello-291 results…
Enhertu improved PFS in HER2-low and ultralow
29 April 2024
Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one…
J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade
…
AstraZeneca: A Triple Shot Of Income, Growth, And Value
…
BHP, Anglo American, Meta, Google, Microsoft, AstraZeneca, Rubrik, ComCast and more
Markets Defused aims to present an easy-to-understand and straightforward recap of the week’s most engaging stock market news BHP takeover approach…
Pharma Stock Roundup: MRK, SNY, AZN, NVS Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.…
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
The global pulmonary drugs market is projected to experience a steady CAGR between 2024 and 2030. This growth is mainly…
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
AZN earnings call for the period ending March 31, 2024.…